Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae

Wiener Klinische Wochenschrift

Volumn 119, Issue 9-10, 2007, Pages 297-302

  Kratzer, Christina ^a   Graninger, Wolfgang ^a   Macfelda, Karin ^a   Buxbaum, Astrid ^a   Georgopoulos, Apostolos ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bronchial epithelial cells; Intracellular activity of antibiotics; Invasion; Non typeable Haemophilus influenzae

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; GENTAMICIN; MOXIFLOXACIN; TELITHROMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BRONCHUS MUCOSA; CELL KILLING; CONTROLLED STUDY; CYTOLYSIS; EPITHELIUM CELL; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; INCUBATION TIME; NONHUMAN;

ADOLESCENT; ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; AZITHROMYCIN; BACTERIAL TYPING TECHNIQUES; BRONCHI; CELLS, CULTURED; CIPROFLOXACIN; EPITHELIAL CELLS; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; KETOLIDES; MALE; QUINOLINES;

EID: 34347361588     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-007-0784-5     Document Type: Article

References (27)

1. Murphy TF (2003) Respiratory infections caused by nontypeable Haemophilus influenzae. Curr Opin Infect Dis 16: 129-134
2. Ketterer MR, Shao JQ, Hornick DB, Buscher B, Bandi VK, Apicella MA (1999) Infection of primary human bronchial epithelial cells by Haemophilus influenzae: Macropinocytosis as a mechanism of airway epithelial cell entry. Infect Immun 67: 4161-4170
3. Swords WE, Buscher BA, Ver Steeg Ii K, Preston A, Nichols WA, Weiser JN, et al (2000) Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol 37: 13-27
4. Ahrén IL, Williams DL, Rice PJ, Forsgren A, Riesbeck K (2001) The importance of a beta-glucan receptor in the nonopsonic entry of non-typeable Haemophilus influenzae into human monocytic and epithelial cells. J Infect Dis 184: 150-158
5. Bandi V, Apicella MA, Mason E, Murphy TF, Siddiqi A, Atmar RL, et al (2001) Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med 164: 2114-2119
6. Murphy TF, Brauer AL, Schiffmacher AT, Sethi S (2004) Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170: 266-272
7. Van Schilfgaarde M, Eijk P, Regelink A, van Ulsen P, Everts V, Dankert J, et al (1999) Haemophilus influenzae localized in epithelial cell layers is shielded from antibiotics and antibody-mediated bactericidal activity. Microbiol Pathogenesis 26: 249-262
8. Ahrén IL, Karlsson E, Forsgren A, Riesbeck K (2002) Comparison of the antibacterial activities of ampicillin, ciprofloxacin, clarithromycin, telithromycin, and quinupristin/dalfopristin against intracellular non-typeable Haemophilus influenzae. J Antimicrob Chemother 50: 903-908
9. Jacobs MR, Johnson CE (2003) Macrolide resistance: an increasing concern for treatment failure in children. Pediatr Infect Dis J 22 [8 Suppl]: S131-S138
10. National Committee for Clinical Laboratory Standards (2003) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Sixth Edition: Approved Standard M7-A6. NCCLS, Wayne, PA, USA
11. Barbé G, Babolat M, Boeufgras, Monget D, Freney (1994) Evaluation of API NH, a new 2-hour system for identification of Neisseria and Haemophilus species and Moraxella catarrhalis in a routine clinical laboratory. J Clin Microbiol 32: 187-189
12. Simon HJ, Yin EL (1970) Microbioassay of antimicrobial agents. Appl Microbiol 19: 573-579
13. Nielsen SL, Obel N, Storgaard M, Andersen PL (1997) The effect of quinolones on the intracellular killing of Staphylococcus aureus in neutrophil granulocytes. J Antimicrob Chemother 39: 617-622
14. Seral C, Van Bambeke F, Tulkens PM (2003) Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. Antimicrob Agents Chemother 47: 2283-2292
15. Bergan T (1982) Penetration of antibiotics into peripheral infection foci. Wien Klin Wochenschr 94: 331-340
16. Foulds G, Shepard RM, Johnson RB (1990) The pharmacokinetics of azithromycin in human serum and tissue. J Antimicrob Chemother 25 [Suppl A]: 73-82
17. Pascual A, Ballesta S, Garcia I, Perea EJ (2001) Uptake and intracellular activity of ketolides HMR 3647 in human phagocytic and non-phagocytic cells. Clin Microbiol Infect 7: 65-69
18. Dan M, Torossian K, Weissberg D, Kitzes R (1993) The penetration of ciprofloxacin into bronchial mucosa, lung parenchyma, and pleural tissue after intravenous administration. Eur J Clin Pharmacol 44: 101-102
19. Pascual A, Gracia I, Ballesta S, Perea EJ (1999) Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells. Antimicrob Agents Chemother 43: 12-15
20. Mandell GL, Coleman EJ (2000) Activities of antimicrobial agents against intracellular pneumococci. Antimicrob Agents Chemother 44: 2561-2563
21. La Penta D, Rubens C, Chi E, Cleary PP (1994) Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci USA 91: 12115-12119
22. Daxboeck F, Bauer CC, Assadian O, Stanek G (2006) An unrecognized epidemic of Mycoplasma pneumoniae infection in Vienna. Wien Klin Wochenschr 118: 208-211
23. Davies B, Maeson F (1979) Serum and sputum antibiotic levels after ampicillin, amoxicillin and bacampicillin in chronic bronchitis patients. Infect 7 [Suppl 5]: 465-468
24. Lode H (1991) The pharmacokinetics of azithromycin and their clinical significance. Eur J Clin Microbiol Infect Dis 10: 807-812
25. Perret C, Lenfant B, Weinling E, Wessels DH, Scholtz HE, Montay G, et al (2002) Pharmacokinetics and absolute oral bioavailability of an 800-mg oral dose of telithromycin in healthy young and elderly volunteers. Chemother 48: 217-223
26. Brunner M, Stabeta H, Moller JG, Schrolnberger C, Erovic B, Holleinstein U, et al (2002) Target site concentrations of ciprofloxacin after single intravenous and oral doses. Antimicrob Agents Chemother 46: 3724-3730
27. Wise R, Andrews JM, Marshall G, et al (1999) Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration. Antimicrob Agents Chemother 43: 1508-1510